Dopamine D
VK4-116
dependance
escalation
opioid
withdrawal
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
10
2019
accepted:
23
12
2019
entrez:
30
1
2020
pubmed:
30
1
2020
medline:
30
1
2020
Statut:
epublish
Résumé
Prescription opioids, such as oxycodone, are highly effective analgesics for clinical pain management, but approximately 25% of patients who are prescribed opioids misuse them, and 5%-10% develop an opioid use disorder (OUD). Effective therapies for the prevention and treatment of opioid abuse and addiction need to be developed. The present study evaluated the effects of the highly selective dopamine D
Identifiants
pubmed: 31992976
doi: 10.3389/fnbeh.2019.00292
pmc: PMC6971096
doi:
Types de publication
Journal Article
Langues
eng
Pagination
292Subventions
Organisme : NIDA NIH HHS
ID : U01 DA044451
Pays : United States
Informations de copyright
Copyright © 2020 de Guglielmo, Kallupi, Sedighim, Newman and George.
Références
J Pharmacol Exp Ther. 2017 Sep;362(3):378-384
pubmed: 28645915
N Engl J Med. 2016 Jan 14;374(2):154-63
pubmed: 26760086
Alcohol Clin Exp Res. 2017 Nov;41(11):1886-1895
pubmed: 28833238
Eur J Pharmacol. 2007 Mar 22;559(2-3):173-9
pubmed: 17303116
Neuropharmacology. 2012 Feb;62(2):1142-51
pubmed: 22119954
Neuropharmacology. 2019 Nov 1;158:107597
pubmed: 30974107
Synapse. 2003 Jun 1;48(3):154-6
pubmed: 12645041
Neuropsychopharmacology. 2013 Jun;38(7):1209-20
pubmed: 23322185
Behav Pharmacol. 2013 Sep;24(5-6):356-62
pubmed: 23839030
J Neurosci. 2002 Nov 1;22(21):9595-603
pubmed: 12417684
Nat Neurosci. 2013 Aug;16(8):1094-100
pubmed: 23817545
Neuropharmacology. 2013 Sep;72:82-7
pubmed: 23643749
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18156-61
pubmed: 23071333
Brain Res. 2006 Jun 20;1095(1):148-53
pubmed: 16712814
Eur Neuropsychopharmacol. 2008 Aug;18(8):551-6
pubmed: 18284941
Eur J Pharmacol. 2011 Jun 1;659(2-3):187-92
pubmed: 21466803
Nat Neurosci. 2002 Jul;5(7):625-6
pubmed: 12055635
J Med Chem. 2015 Jul 23;58(14):5361-80
pubmed: 25826710
Neuropsychopharmacology. 2003 Jul;28(7):1272-80
pubmed: 12700694
Methods Mol Biol. 2017;1488:31-44
pubmed: 27933519
Science. 1998 Oct 9;282(5387):298-300
pubmed: 9765157
BMJ. 2013 May 03;346:f2690
pubmed: 23645858
J Neurosci. 2012 May 30;32(22):7563-71
pubmed: 22649234
Psychopharmacology (Berl). 2014 Apr;231(7):1277-87
pubmed: 24221825
Neuropharmacology. 2017 Nov;126:190-199
pubmed: 28888944
Neuropsychopharmacology. 2017 Aug;42(9):1925-1926
pubmed: 28701746
Annu Rev Public Health. 2015 Mar 18;36:559-74
pubmed: 25581144
Alcohol Clin Exp Res. 1984 Sep-Oct;8(5):477-9
pubmed: 6391259
Eur J Neurosci. 2017 Jan;45(1):2-19
pubmed: 27600596
J Med Chem. 2015 Aug 13;58(15):6195-213
pubmed: 26203768
PLoS One. 2007 Aug 01;2(8):e698
pubmed: 17668074
CNS Drug Rev. 2007 Summer;13(2):240-59
pubmed: 17627675
Annu Rev Pharmacol Toxicol. 2016;56:299-322
pubmed: 26514207
Neuropsychopharmacology. 2019 Jul;44(8):1415-1424
pubmed: 30555159
Appetite. 2012 Aug;59(1):27-33
pubmed: 22445776
Science. 2004 Aug 13;305(5686):1017-9
pubmed: 15310907
J Pharmacol Exp Ther. 2015 Sep;354(3):484-92
pubmed: 26177654
eNeuro. 2018 Jul 2;5(3):
pubmed: 29971251
Neuropsychopharmacology. 2015 Mar;40(4):927-37
pubmed: 25311134
Neuropharmacology. 2019 Jun;151:127-135
pubmed: 30980837
Eur J Neurosci. 2012 Mar;35(5):775-83
pubmed: 22304754
J Pharmacol Exp Ther. 2019 Dec;371(3):602-614
pubmed: 31562201
Pflugers Arch. 1992 Feb;420(2):194-9
pubmed: 1620578
Neuropsychopharmacology. 2015 Jan;40(2):421-8
pubmed: 25060491
Neuropsychopharmacology. 2013 Jan;38(2):302-12
pubmed: 22968817
J Med Chem. 2016 Aug 25;59(16):7634-50
pubmed: 27508895
J Genet Psychol. 1968 Sep;113(1st Half):53-63
pubmed: 5751370
Psychopharmacology (Berl). 2014 Oct;231(19):3911-7
pubmed: 24923982
Dev Psychobiol. 1986 Mar;19(2):105-11
pubmed: 3699254
Sci Adv. 2018 Oct 17;4(10):eaat4751
pubmed: 30345354
Biol Psychiatry. 2020 Jan 1;87(1):44-53
pubmed: 31400808
J Sex Med. 2009 Apr;6(4):980-988
pubmed: 19207271
Psychopharmacology (Berl). 2008 Mar;196(4):533-42
pubmed: 17985117
Behav Pharmacol. 2005 May;16(3):181-6
pubmed: 15864073
Eur J Neurosci. 2005 Jun;21(12):3427-38
pubmed: 16026480
Annu Rev Pharmacol Toxicol. 1980;20:441-62
pubmed: 7387124
Arch Gen Psychiatry. 1990 Apr;47(4):325-30
pubmed: 2157379
Synapse. 2012 Jan;66(1):85-7
pubmed: 21905128
Neuropsychopharmacology. 2008 Sep;33(10):2474-82
pubmed: 18033234
Drug Alcohol Depend. 2015 Nov 1;156:228-233
pubmed: 26429728
Int J Neuropsychopharmacol. 2006 Oct;9(5):585-602
pubmed: 16942635
Ann N Y Acad Sci. 2010 Feb;1187:4-34
pubmed: 20201845
Neuropsychopharmacology. 2006 Mar;31(3):563-71
pubmed: 16034440
Psychopharmacology (Berl). 2017 Mar;234(6):977-987
pubmed: 28127624
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Pharmacol Biochem Behav. 2011 Jun;98(4):570-4
pubmed: 21406200
Eur Neuropsychopharmacol. 2008 Apr;18(4):303-11
pubmed: 17920248